| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
147,600
|
— | ₹1.49 |
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | 2,946,000 |
100% | ₹29.75 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| Market Maker | 147,600 | ₹1.49 |
5.01%
|
| Total | 2,946,000 | ₹29.75 |
100.00%
|
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 2,400 | ₹242,400 |
| Retail (Max — 13 Lots) | 13 | 15,600 | ₹1,575,600 |
| S-HNI (Min — 14 Lots) | 14 | 16,800 | ₹1,696,800 |
| B-HNI (Min — 68 Lots) | 68 | 81,600 | ₹8,241,600 |
| Particulars | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue from Operations | 35.75 | 33.94 | 29.53 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 5.24 | 3.88 | 0.10 |
| Net Worth | 13.58 | 5.35 | 3.84 |
| Total Assets | 39.99 | 27.05 | 20.58 |
| Reserves & Surplus | 5.41 | 1.35 | 0.00 |
| Borrowings | 13.79 | 13.48 | 8.47 |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | 11.51% | — | — |
Accretion Pharmaceuticals Ltd IPO is subscribed 1.00 times by May 16, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Accretion Pharmaceuticals Ltd IPO retail category is subscribed 1.00 times as of 16 May 2025. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 14 May 2025 and closes 16 May 2025. Min investment: ₹121,200 (1 lot = 1,200 shares). UPI mandate: 5:00 PM on 16 May 2025.
The Accretion Pharmaceuticals Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website (Kfin Technologies Ltd) at https://ipostatus.kfintech.com/. Enter your PAN, application number or DP/Client ID. Allotment date: 19 May 2025. Refunds: on 20 May 2025.
The Accretion Pharmaceuticals Ltd IPO listing date is 21 May 2025, Wednesday. Listed on: NSE SME. Issue price: ₹101. Estimated listing: ₹101. GMP: NIL.
The Accretion Pharmaceuticals Ltd IPO closes on 16 May 2025, Friday. UPI mandate: 5:00 PM on 16 May 2025. Allotment: 19 May 2025. Listing: 21 May 2025.